Processa pharmaceuticals to participate in upcoming investor conferences

Hanover, md., may 18, 2021 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), (“processa” or the “company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced today that management will participate in two upcoming investor conferences:
PCSA Ratings Summary
PCSA Quant Ranking